Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-113149
Filing Date
2024-12-27
Accepted
2024-12-27 17:00:41
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0225656-10k_citius.htm   iXBRL 10-K 1376710
2 DESCRIPTION OF COMMON STOCK ea022565601ex4-22_citius.htm EX-4.22 17242
3 INSIDER TRADING POLICY ea022565601ex19-1_citius.htm EX-19.1 37106
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea022565601ex23-1_citius.htm EX-23.1 1790
5 CERTIFICATION ea022565601ex31-1_citius.htm EX-31.1 9665
6 CERTIFICATION ea022565601ex31-2_citius.htm EX-31.2 10032
7 CERTIFICATION ea022565601ex32-1_citius.htm EX-32.1 4497
  Complete submission text file 0001213900-24-113149.txt   6073292

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ctxr-20240930.xsd EX-101.SCH 52432
9 XBRL CALCULATION FILE ctxr-20240930_cal.xml EX-101.CAL 40709
10 XBRL DEFINITION FILE ctxr-20240930_def.xml EX-101.DEF 262162
11 XBRL LABEL FILE ctxr-20240930_lab.xml EX-101.LAB 490654
12 XBRL PRESENTATION FILE ctxr-20240930_pre.xml EX-101.PRE 275087
73 EXTRACTED XBRL INSTANCE DOCUMENT ea0225656-10k_citius_htm.xml XML 520148
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 241586207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)